Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
St Jude Medical
>
Riata / Durata More Bad News!!!!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4095404"]Here's a little piece.. The time frame will be shorter though and Dr's will stop implanting Durata because its the same internal design </p><p><br /></p><p>Here comes the BOOM........</p><p><br /></p><p>Summary. Based on our physician checks, we expect the problems with the</p><p>STJ Riata ICD lead to become more visible within the medical community over</p><p>the next 6-9 months. In our view, the degree to which this impacts STJ’s ICD</p><p>business (33% of total STJ sales) will depend on (1) the scope of the problem; (2)</p><p>how well STJ handles the issue; (3) how STJ recommends managing active Riata</p><p>patients; (4) the competitor response; and (5) any actual or perceived spillover to</p><p>STJ’s newer Durata lead. At the very least, we think the increased prominence of</p><p>this issue will make it more difficult for STJ to gain share in the ICD market,</p><p>which is a key component of the bull case on this name. If STJ does not handle</p><p>this issue well, it could result in the company losing share to MDT and BSX. We</p><p>are lowering our valuation range to $36-38 from $49-50 to reflect the recent</p><p>softness in cardiology procedures, the strengthening of the dollar vs. the Euro,</p><p>and the Riata issues described in this note.</p><p>• We Expect The Noise Level Around Riata To Increase. Over the next 6-</p><p>9 months, we expect additional studies on the Riata malfunction rate to be</p><p>presented at medical meetings such as the American College of Cardiology (ACC)</p><p>in March 2012 and the Heart Rhythm Society (HRS) meeting in May 2012.</p><p>Physicians with whom we have spoken expect the failure rate in the recently</p><p>presented Irish study (15%) to be replicated based on the relatively high number</p><p>of Riata insulation defects seen in the FDA MAUDE database. At some point, we</p><p>would expect STJ to issue recommendations on how to screen and manage these</p><p>patients. If STJ recommends conducting a fluoroscopy on these patients every</p><p>3-6 months, we think a large number of patients with insulation defects will be</p><p>identified and the nuisance of screening such a large number of patients may</p><p>cause some backlash against STJ among implanters.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4095404"]Here's a little piece.. The time frame will be shorter though and Dr's will stop implanting Durata because its the same internal design Here comes the BOOM........ Summary. Based on our physician checks, we expect the problems with the STJ Riata ICD lead to become more visible within the medical community over the next 6-9 months. In our view, the degree to which this impacts STJ’s ICD business (33% of total STJ sales) will depend on (1) the scope of the problem; (2) how well STJ handles the issue; (3) how STJ recommends managing active Riata patients; (4) the competitor response; and (5) any actual or perceived spillover to STJ’s newer Durata lead. At the very least, we think the increased prominence of this issue will make it more difficult for STJ to gain share in the ICD market, which is a key component of the bull case on this name. If STJ does not handle this issue well, it could result in the company losing share to MDT and BSX. We are lowering our valuation range to $36-38 from $49-50 to reflect the recent softness in cardiology procedures, the strengthening of the dollar vs. the Euro, and the Riata issues described in this note. • We Expect The Noise Level Around Riata To Increase. Over the next 6- 9 months, we expect additional studies on the Riata malfunction rate to be presented at medical meetings such as the American College of Cardiology (ACC) in March 2012 and the Heart Rhythm Society (HRS) meeting in May 2012. Physicians with whom we have spoken expect the failure rate in the recently presented Irish study (15%) to be replicated based on the relatively high number of Riata insulation defects seen in the FDA MAUDE database. At some point, we would expect STJ to issue recommendations on how to screen and manage these patients. If STJ recommends conducting a fluoroscopy on these patients every 3-6 months, we think a large number of patients with insulation defects will be identified and the nuisance of screening such a large number of patients may cause some backlash against STJ among implanters.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
St Jude Medical
>
Riata / Durata More Bad News!!!!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
St Jude Medical
>
Riata / Durata More Bad News!!!!
>